Literature DB >> 26201782

Population-attributable estimates for risk factors associated with hepatitis B and C: policy implications for Pakistan and other South Asian countries.

Bilal Ahmed1, Tooba Ali2, Huma Qureshi3, Saeed Hamid4.   

Abstract

INTRODUCTION: Reuse of contaminated syringes, high frequency of injections, tattooing and skin piercing have repeatedly been shown to be important and independent risk factors for the transmission of hepatitis B (HBV) and C (HCV) infections in South Asian countries. Estimation of population-attributable risks indicates the potential for hepatitis prevention if the exposure to certain modifiable factors can be eliminated.
METHODS: We estimated the population-attributable risks of various risk factors for transmission of HBV and HCV using data from a large, nationally representative survey conducted in 2007 across Pakistan, a country known to have a high prevalence of chronic viral hepatitis. Odds ratio estimates and observed prevalence of the risk factors were used for calculating PAR estimates. We also performed a systematic review of published studies that identify the prevalence of similar modifiable risk factors for HBV and HCV from other South Asian countries in order to define an overall prevention strategy for the region.
RESULTS: For HBV, a high frequency (>10) of therapeutic injections in the past 1 year had an attributable risk of 3.5 % (95 % CI 2.9-3.9), reuse of syringes had a 2.7 % risk (95 % CI 2.2-3.1), the practice of being shaved by a barber 2.1 % (95 % CI 1.7-2.6), sharing of smoking utensils 4.4 % (95 % CI 3.8-4.9) and ear/nose piercing 1.4 % (95 % CI 1.2-1.7). Population-attributable risks for HCV were as follows: high frequency of therapeutic injections in the past 1 year 11.3 % (95 % CI 10.5-11.7), reuse of syringes 6.2 % (95 % CI 6.1-6.9), practice of being shaved by a barber shop 7.9 % (95 % CI 7.1-8.2), sharing of smoking utensils 8.1 % (95 % CI 6.9-8.5), practice of ear/nose piercing among females 5.9 % (95 % CI 5.2-6.1) and tattooing 5 % (95 % CI 4.3-5.6). A systematic review showed that other South Asian countries share a number of common risk factors for the transmission of viral hepatitis.
CONCLUSION: A substantial number of HBV and HCV infections in Pakistan and other South Asian countries can be prevented by key interventions targeted toward a few selected and modifiable risk factors. Hence, policies specifically targeted at key risk factors for HBV and HCV such as safe and rational use of injections prescribed by trained health-care providers are urgently needed for countries like Pakistan.

Entities:  

Keywords:  Hepatitis B; Hepatitis C; Pakistan; Population-attributable risk; South Asia

Year:  2013        PMID: 26201782     DOI: 10.1007/s12072-012-9417-9

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  46 in total

Review 1.  Is severe liver disease a common outcome for people with chronic hepatitis C?

Authors:  Gregory J Dore; Anthony J Freeman; Matthew Law; John M Kaldor
Journal:  J Gastroenterol Hepatol       Date:  2002-04       Impact factor: 4.029

2.  Knowledge and practices of barbers about hepatitis B and C transmission in Rawalpindi and Islamabad.

Authors:  N Z Janjua; M A M Nizamy
Journal:  J Pak Med Assoc       Date:  2004-03       Impact factor: 0.781

3.  Risk factors for chronic hepatitis B virus infection among blood donors in Bangalore, India.

Authors:  L Jagannathan; M Chaturvedi; S Mudaliar; T Kamaladoss; M Rice; E L Murphy
Journal:  Transfus Med       Date:  2010-08-18       Impact factor: 2.019

Review 4.  Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.

Authors:  Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt
Journal:  Lancet       Date:  2011-07-27       Impact factor: 79.321

5.  Injection use in two districts of Pakistan: implications for disease prevention.

Authors:  Naveed Zafar Janjua; Saeed Akhtar; Yvan J F Hutin
Journal:  Int J Qual Health Care       Date:  2005-05-09       Impact factor: 2.038

6.  Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.

Authors:  T Shirin; T Ahmed; A Iqbal; M Islam; M N Islam
Journal:  J Health Popul Nutr       Date:  2000-12       Impact factor: 2.000

7.  The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan.

Authors:  S P Luby; K Qamruddin; A A Shah; A Omair; O Pahsa; A J Khan; J B McCormick; F Hoodbhouy; S Fisher-Hoch
Journal:  Epidemiol Infect       Date:  1997-12       Impact factor: 2.451

8.  Hepatitis C - contamination of toothbrushes: myth or reality?

Authors:  G Lock; M Dirscherl; F Obermeier; C M Gelbmann; C Hellerbrand; A Knöll; J Schölmerich; W Jilg
Journal:  J Viral Hepat       Date:  2006-09       Impact factor: 3.728

Review 9.  Epidemiology of hepatitis B and C viruses: a global overview.

Authors:  Helen S Te; Donald M Jensen
Journal:  Clin Liver Dis       Date:  2010-02       Impact factor: 6.126

10.  A comprehensive situation assessment of injection practices in primary health care hospitals in Bangladesh.

Authors:  A K Azad Chowdhury; Tapash Roy; A B M Faroque; Sitesh C Bachar; Muhammad Asaduzzaman; Nishat Nasrin; Nahid Akter; Hamidur Rahman Gazi; Abul Kalam Lutful Kabir; Masuma Parvin; Claire Anderson
Journal:  BMC Public Health       Date:  2011-10-10       Impact factor: 3.295

View more
  8 in total

Review 1.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

2.  Examining unsafe injection practices associated with auto-disable (AD) syringes: a systematic review.

Authors:  Anokhi Ali Khan; Mehr Munir; Fatima Miraj; Shayan Imran; Danya Arif Siddiqi; Arshad Altaf; Aamir Javed Khan; Subhash Chandir
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

Review 3.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

4.  Screening of adult dental patients visiting Khyber College of Dentistry, Peshawar for HBV and HCV infections and identifying the associated risk factors.

Authors:  Jamila Haider; Ghosia Lufullah; Rubina Nazli; Tasleem Akhtar; Asma Shah
Journal:  Pak J Med Sci       Date:  2017 May-Jun       Impact factor: 1.088

5.  Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis.

Authors:  Aaron G Lim; Nick Scott; Josephine G Walker; Saeed Hamid; Margaret Hellard; Peter Vickerman
Journal:  PLoS Med       Date:  2021-10-19       Impact factor: 11.069

Review 6.  Viral Hepatitis in Pakistan: Past, Present, and Future.

Authors:  Amna Subhan Butt; Fatima Sharif
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09

7.  From risk to care: the hepatitis C screening and diagnostic cascade in a primary health care clinic in Karachi, Pakistan-a cohort study.

Authors:  Gul Ghuttai Khalid; Khine Wut Yee Kyaw; Christine Bousquet; Rosa Auat; Dmytro Donchuk; Adam Trickey; Saeed Hamid; Huma Qureshi; Valentina Mazzeo; Khawar Aslam; Salima Khowaja; Rafael Van den Bergh
Journal:  Int Health       Date:  2020-01-01       Impact factor: 2.473

Review 8.  Transmission of Hepatitis B and C Virus Infection Through Body Piercing: A Systematic Review and Meta-Analysis.

Authors:  Shigui Yang; Dan Wang; Yuelun Zhang; Chengbo Yu; Jingjing Ren; Kaijin Xu; Min Deng; Guo Tian; Cheng Ding; Qing Cao; Yiping Li; Ping Chen; Tiansheng Xie; Chencheng Wang; Bing Wang; Jun Yao; Diane Threapleton; Chen Mao; Bing Ruan; Lanjuan Li
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.